DOCSLIB.ORG

Meeting Report Prevention and Treatment of HIV/AIDS Among Drug Using Populations: a Global Perspective

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Meeting Report Prevention and Treatment of HIV/AIDS Among Drug Using Populations: a Global Perspective Meeting Report Prevention and Treatment of HIV/AIDS among Drug Using Populations: A Global Perspective Meeting supported by the National Institute on Drug Abuse and the International AIDS Society January 11-12, 2010 Washington, D.C. www.iasociety.org Table of Contents Table of Contents .............................................................................................................................................................i Executive Summary .........................................................................................................................................................1 Overview of the Report ..................................................................................................................................................... 1 Chapter 1. Introduction..................................................................................................................................................3 A Timely Opportunity: Why This Meeting Was Held ...................................................................................................... 3 Process and Outcomes ...................................................................................................................................................... 4 Chapter 2. Global Strategy for HIV and Drug Use .......................................................................................................5 President’s Emergency Plan for AIDS Relief ...................................................................................................................... 5 Office of National AIDS Policy ......................................................................................................................................... 7 Office of National Drug Control Policy ............................................................................................................................ 8 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention ..... 9 Office of AIDS Research ................................................................................................................................................ 10 National Institute of Allergy and Infectious Diseases ...................................................................................................... 12 United Nations Joint Programme on HIV/AIDS ............................................................................................................ 14 Conclusion ..................................................................................................................................................................... 15 References ....................................................................................................................................................................... 17 Chapter 3. Comprehensive Approaches to HIV Prevention for People Who Use Drugs ...............................................19 The Case for Comprehensive HIV Prevention for Injection Drug Users .......................................................................... 19 Challenges of Drug-Using Populations ........................................................................................................................... 22 Substance Abuse Treatment as HIV Prevention .............................................................................................................. 24 HCV and TB Co-infection and Drug–Drug Interactions in Substance Users .................................................................. 27 Future Directions ........................................................................................................................................................... 30 Conclusion ..................................................................................................................................................................... 30 References ....................................................................................................................................................................... 31 Chapter 4. Expanded HAART to Improve Individual and Public Health Outcomes ....................................................37 Seek, Test, Treat, and Retain ........................................................................................................................................... 37 HIV/AIDS Treatment for Drug-Using Populations ......................................................................................................... 40 Adherence to ART among Drug-Using Populations ........................................................................................................ 43 Conclusion ..................................................................................................................................................................... 46 References ....................................................................................................................................................................... 48 Chapter 5. Drug Abuse, HIV/AIDS, and the Criminal Justice System: Challenges and Opportunities ........................55 The “War on Drugs” and Increased Incarceration of Drug Abusers ................................................................................. 55 HIV Transmission and Prevention Strategies in Prisons ................................................................................................... 56 Opportunity to Implement “Seek, Test, Treat, and Retain” in Corrections Populations ................................................... 57 HIV Treatment in Prison ............................................................................................................................................... 58 Linkages to Care upon Community Reentry ................................................................................................................... 58 TB and HCV Infection in Criminal Justice Settings ....................................................................................................... 59 Conclusion and Recommendations ................................................................................................................................. 59 References ....................................................................................................................................................................... 61 Table of Contents i Chapter 6. Human Rights and At-Risk and Vulnerable Populations ............................................................................65 Stigma, Discrimination, and Vulnerability to HIV .......................................................................................................... 66 Gender Inequality ........................................................................................................................................................... 67 Sex Workers .................................................................................................................................................................... 68 Men Who Have Sex with Men ....................................................................................................................................... 70 Conclusion ..................................................................................................................................................................... 71 References ....................................................................................................................................................................... 72 Appendix A: Breakout Group Recommendations .........................................................................................................75 Breakout Group 1: Optimizing HIV Prevention Modalities ............................................................................................ 75 Breakout Group 2: Drug Abuse Treatment as HIV Prevention ........................................................................................ 76 Breakout Group 3: HIV Prevention Implementation: Integration and Rolling Out ........................................................ 77 Breakout Group 4: ART Therapy as HIV Prevention: Seek, Test, and Treat ..................................................................... 78 Breakout Group 5: Human Rights and Vulnerable Populations ....................................................................................... 79 Breakout Group 6: HIV/AIDS Treatment ....................................................................................................................... 80 Breakout Group 7: Comorbidity and Adherence ............................................................................................................. 81 Breakout Group 8: Criminal Justice: HIV Prevention and Treatment .............................................................................. 82 Appendix B: Meeting Agenda .......................................................................................................................................83 Appendix C: Participant List 2010 Consultation Meeting ...........................................................................................87 ii Prevention and Treatment of HIV/AIDS among Drug Using Populations: A Global Perspective Executive Summary On January 11–12, 2010, the National Institute on Drug Overview
Load more

Recommended publications
  • Executive Branch
    EXECUTIVE BRANCH THE PRESIDENT BARACK H. OBAMA, Senator from Illinois and 44th President of the United States; born in Honolulu, Hawaii, August 4, 1961; received a B.A. in 1983 from Columbia University, New York City; worked as a community organizer in Chicago, IL; studied law at Harvard University, where he became the first African American president of the Harvard Law Review, and received a J.D. in 1991; practiced law in Chicago, IL; lecturer on constitutional law, University of Chicago; member, Illinois State Senate, 1997–2004; elected as a Democrat to the U.S. Senate in 2004; and served from January 3, 2005, to November 16, 2008, when he resigned from office, having been elected President; family: married to Michelle; two children: Malia and Sasha; elected as President of the United States on November 4, 2008, and took the oath of office on January 20, 2009. EXECUTIVE OFFICE OF THE PRESIDENT 1600 Pennsylvania Avenue, NW., 20500 Eisenhower Executive Office Building (EEOB), 17th Street and Pennsylvania Avenue, NW., 20500, phone (202) 456–1414, http://www.whitehouse.gov The President of the United States.—Barack H. Obama. Personal Aide to the President.—Katherine Johnson. Special Assistant to the President and Personal Aide.—Reginald Love. OFFICE OF THE VICE PRESIDENT phone (202) 456–1414 The Vice President.—Joseph R. Biden, Jr. Chief of Staff to the Vice President.—Bruce Reed, EEOB, room 202, 456–9000. Deputy Chief of Staff to the Vice President.—Alan Hoffman, EEOB, room 202, 456–9000. Counsel to the Vice President.—Cynthia Hogan, EEOB, room 246, 456–3241.
    [Show full text]
  • The US Government's Global Health Policy Architecture
    U.S. GLOBAL HEALTH POLICY THE U.S. GOVERNMENT’S GLOBAL HEALTH POLICY ARCHITECTURE: Structure, Programs, and Funding April 2009 U.S. GLOBAL HEALTH POLICY THE U.S. GOVERNMENT’S GLOBAL HEALTH POLICY ARCHITECTURE: Structure, Programs, and Funding April 2009 Jen Kates Kaiser Family Foundation Julie Fischer Stimson Center Eric Lief Stimson Center Acknowledgments The development of this report was informed by discussions with several individuals, including an ongoing dialogue with J. Stephen Morrison of the Center for Strategic & International Studies (CSIS) regarding the formation of the CSIS Commission on Smart Global Health Policy; Phillip Nieburg, Centers for Strategic & International Studies; Ruth Levine, Center for Global Development; and Erin Thornton, ONE Campaign In addition, much of the data used in this analysis were collected through a contract with the Stimson Center, under the direction of Julie Fischer and Eric Lief, with their colleague, Vidal Seegobin. This report was supported in part by a grant from the Bill & Melinda Gates Foundation. Table of Contents EXECUTIVE SUMMARY _______________________________________________________________ 1 INTRODUCTION _____________________________________________________________________ 3 DEFINING THE SCOPE AND ROLE OF THE U.S. GOVERNMENT’S GLOBAL HEAlth ENGAGEMENT ______________________________________________________ 4 U.S. GOVERNMENT FUNDING FOR GLOBAL HEAlth ____________________________________ 5 MAJOR GOVERNING STATUTES, AUTHORITIES, AND POLICIES FOR U.S. GLOBAL HEAlth ___________________________________________________________
    [Show full text]
  • 8Th IAS Conference on HIV Pathogenesis, Treatment &
    ONLINE ONLINE OPEN PEER-REVIEWD PEER-REVIEWD ONLINE A PEER-REVIEWD OPEN ACCESS OPEN HIV/AIDS JOURNAL HIV/AIDS JOURNAL CCESS ONLINEONLINE CCESS A OPEN OPEN PEER-REVIEWD ONLINE HIV/AIDS JOURNAL HIV/AIDS HIV/AIDS JOURNAL PEER-REVIEWD PEER-REVIEWD OPEN ACCESSONLINEPEER-REVIEWD A ONLINEPEER-REVIEWD CCESS HIV/AIDS JOURNALPEER-REVIEWD OPEN ACCESS CCESS A OPEN ONLINE ONLINE HIV/AIDS JOURNAL ONLINE PEER-REVIEWDHIV/AIDS JOURNALONLINEONLINE PEER-REVIEWDOPEN ACCESS PEER-REVIEWD ONLINE ONLINE OPEN ACCESSONLINE OPEN HIV/AIDS JOURNAL CCESS OPEN ACCESS HIV/AIDS JOURNAL PEER-REVIEWD PEER-REVIEWD PEER-REVIEWD HIV/AIDS JOURNAL PEER-REVIEWD A HIV/AIDS JOURNAL OPEN ACCESS PEER-REVIEWD PEER-REVIEWD PEER-REVIEWDONLINE HIV/AIDS JOURNAL HIV/AIDS JOURNAL OPEN ACCESS ONLINE ONLINEONLINE HIV/AIDS JOURNAL HIV/AIDS PEER-REVIEWD A PEER-REVIEWD ONLINE ONLINE HIV/AIDS JOURNAL CCESS HIV/AIDS JOURNALOPEN ONLINE PEER-REVIEWDONLINE PEER-REVIEWD HIV/AIDS JOURNAL OPEN PEER-REVIEWDJOURNAL HIV/AIDS HIV/AIDS JOURNAL HIV/AIDS JOURNAL CCESS ONLINE A A ONLINE OPEN ACCESS HIV/AIDS JOURNAL ONLINE HIV/AIDS JOURNAL CCESS PEER-REVIEWD OPEN ACCESS HIV/AIDS JOURNAL OPEN ACCESS ONLINE HIV/AIDS JOURNAL HIV/AIDS ONLINE OPEN OPEN ACCESS HIV/AIDS JOURNAL PEER-REVIEWD OPEN HIV/AIDS JOURNALPEER-REVIEWD PEER-REVIEWD OPEN ACCESS PEER-REVIEWD CCESS A OPEN PEER-REVIEWDONLINE PEER-REVIEWD PEER-REVIEWD HIV/AIDS JOURNALAbstractHIV/AIDS JOURNAL SupplementHIV/AIDS JOURNAL PEER-REVIEWD OPEN ACCESS CCESS PEER-REVIEWD A PEER-REVIEWD A 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention CCESS OPEN ACCESS 19–22 July 2015, Vancouver, Canada OPEN HIV/AIDS JOURNAL Volume 18, Supplement 4 Scan this QR code with your mobile device to view July 2015 the special issue online 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) Journal of the International AIDS Society 2015, 18 (Suppl 4) http://www.jiasociety.org/index.php/jias/article/view/20479 ORAL ABSTRACTS Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice resulted in viral amplification MO Á MONDAY in the mouse.
    [Show full text]
  • BRIEF of FORMER MEMBERS of CONGRESS AS AMICI CURIAE in 18 V
    Case 4:19-cv-00892-HSG Document 66-2 Filed 05/01/19 Page 1 of 37 1 ARNOLD & PORTER KAYE SCHOLER LLP Irvin B. Nathan* 2 Robert N. Weiner* Andrew T. Tutt* 3 Kaitlin Konkel* Samuel F. Callahan* 4 601 Massachusetts Ave, NW Washington, DC 20001 5 Telephone: (202) 942-5000 [email protected] 6 *Pro hac vice application forthcoming 7 Douglas A. Winthrop (SBN 183532) Three Embarcadero Center, 10th Floor 8 San Francisco, CA 94111 Telephone: (415) 471-3100 9 [email protected] 10 Counsel for Amici Curiae Former Members of Congress 11 12 UNITED STATES DISTRICT COURT 13 NORTHERN DISTRICT OF CALIFORNIA 14 OAKLAND DIVISION 15 16 SIERRA CLUB, et al., Case No.: 4:19-cv-00892-HSG 17 Plaintiffs, BRIEF OF FORMER MEMBERS OF CONGRESS AS AMICI CURIAE IN 18 v. SUPPORT OF PLAINTIFFS’ MOTION FOR PRELIMINARY INJUNCTION 19 DONALD J. TRUMP, President of the United States, in his official capacity, et. al., 20 P.I. Hearing: May 17, 2019, at 10:00 AM Defendants. 21 22 23 24 25 26 27 28 Brief of Former Members of Congress as Amici Curiae (4:19-cv-00892-HSG) Case 4:19-cv-00892-HSG Document 66-2 Filed 05/01/19 Page 2 of 37 1 TABLE OF CONTENTS Page 2 TABLE OF AUTHORITIES ........................................................................................................... iii 3 INTEREST OF AMICI CURIAE ......................................................................................................1 4 INTRODUCTION AND SUMMARY OF ARGUMENT ................................................................2 5 ARGUMENT .....................................................................................................................................3 6 I. THE PRESIDENT HAS DECLARED A PATENTLY FICTITIOUS EMERGENCY ..........3 7 II. THE EXECUTIVE BRANCH IS UNDERMINING THE SEPARATION OF POWERS 8 BY USURPING THE APPROPRIATIONS POWER VESTED EXCLUSIVELY IN CONGRESS .......................................................................................................................6 9 A.
    [Show full text]
  • STOP HIV/AIDS Backgrounder
    TREATMENT AS PREVENTION STOP HIV/AIDS STOP HIV/AIDS In 2008, the BC-CfE developed a mathematical On February 4, 2010, then-Minister of Health “TREATMENT AS model and a cost-effectiveness evaluation Kevin Falcon announced a four-year $48 million that suggested that the expansion of HAART pilot aimed to evaluate the impact of the HIV PREVENTION” IN coverage would be highly cost-effective, as it Treatment as Prevention strategy in BC. The would prevent AIDS morbidity and mortality. strategy is a pilot project called STOP HIV/AIDS ACTION However, when the impact of the expansion of (Seek and Treat for Optimal Prevention of HIV HAART coverage on HIV transmission was taken and AIDS). Extending HAART via Treatment as into account, the strategy was found to have the The STOP HIV/AIDS pilot aims to expand access Prevention saves lives, prevents potential of becoming cost-averting, as it would to HIV/AIDS treatment and medication among HIV transmission and reduces health costs virtually eliminate vertical transmission of HIV, hard-to-reach and vulnerable populations in and dramatically reduce HIV transmission by all hile an outright cure or a preventive Vancouver’s Downtown Eastside and Prince other routes. Wvaccine for HIV/AIDS remains elusive, George. These regions had been identified as remarkable advances in HIV treatment have Most recently, HPTN 052—a randomized trial of priority sites for the pilot project because they been achieved over the past two decades. HIV sero-discordant (primarily heterosexual) were disproportionately affected by HIV/AIDS. Most significant among these advances is the couples—provided definitive proof of the The pilot project specifically serves individuals development of highly active antiretroviral efficacy of HIV Treatment as Prevention.
    [Show full text]
  • Killam Prizes | Prix Killam
    Killam Prizes | Prix Killam Year | Winners | University | Discipline Année Gagnants Université 2021 Michel Bouvier Université de Montréal Health Sciences | sciences de la santé Stephen R. Gill York University Social Sciences | sciences sociales Gilbert Laporte HEC Montréal Engineering | génie Arthur Ripstein University of Toronto Humanities | sciences humaines Douglas Stephan University of Toronto Natural Sciences | sciences de la nature 2020 Cecilia Benoit University of Victoria Social Sciences | sciences sociales Sarah Carter University of Alberta Humanities | sciences humaines Alan Evans Montreal Neurological Institute Health Sciences | sciences de la santé Ted Sargent University of Toronto Engineering | génie Barbara Sherwood Lollar University of Toronto Natural Sciences | sciences de la nature 2019 Yoshua Bengio Université de Montréal Natural Sciences | sciences de la nature André Blais Université de Montréal Social Sciences | sciences sociales Keith W. Hipel University of Waterloo Engineering | génie Stephen W. Scherer University of Toronto Health Sciences | sciences de la santé Lynne Viola University of Toronto Humanities | sciences humaines 2018 André Gaudreault Université de Montréal Humanities | sciences humaines Vladimir Hachinski Western University Health Sciences | sciences de la santé Walter Herzog University of Calgary Engineering | génie James Pinfold University of Alberta Natural Sciences | sciences de la nature Janet Werker University of British Columbia Social Sciences | sciences sociales Canada Council for the Arts
    [Show full text]
  • Department/Agency Name Position
    Department/Agency Name Position Status Date Advisory Committee for Trade Policy and Negotiations Jill Appell Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Pamel G. Bailey Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations C. Fred Bergstein Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Bobbi Brown Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Michael E. Campbell Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Lisa Carty Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Governor Chris Christie Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Michael Ducker Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Mayor Buddy Dyer Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations John B. Emerson Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Bill Frenzel Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Dean Garfield Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Leo W. Gerard Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Joseph T. Hansen Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations James P. Hoffa Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Robert Holleyman Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Sandra Kennedy Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Jim Kolbe Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Fred Krupp Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations David Lane Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Kase Lawal Member Appointed 9/15/2010 Advisory Committee for Trade Policy and Negotiations Robert A.
    [Show full text]
  • 30 Years Is ENUF!
    AIDS30 Years Is ENUF! The History of the AIDS Epidemic in Black America Black AIDS Institute June 2011 AIDS: 30 Years Is Enuf! The History of the AIDS Epidemic in Black America, 2011 is a publication of the Black AIDS Institute, 1833 West Eighth Street, Los Angeles, California 90057-4257, 213-353-3610, 213-989-0181 fax, [email protected], www.BlackAIDS.org. © 2011 Black AIDS Institute. All rights reserved. The slogan “Our People, Our Problem, Our Solution” is a trademark of the Black AIDS Institute. Views and opinions expressed in this publication are not necessarily those of the Black AIDS Institute, its partners or the funders of this publication. Publication of the name or photograph of a person does not indicate the sexual orientation or HIV status of the person or necessarily constitute an en dorse ment of the Institute or its policies. Some photographs in this publication use professional models. AIDS: 30 Years Is Enuf! The History of the AIDS Epidemic in Black America, 2011 is designed for educational purposes only and is not en gaged in rendering medical advice or profession al services. The information provided through this publication should not be used for diagnos ing or treating a health problem or a disease. It is not a sub stitute for profes sional care. This report was made possible, in part, by the generous support of the Elton John AIDS Foundation, Ford Foundation, MAC AIDS Fund, John M. Lloyd Foundation and Broadway Cares/Equity Fights AIDS. Table of Contents 4 From the CEO 8 Forward by Rosalyn Brock and Benjamin Todd Jealous 10 Executive Summary 16 The History of the AIDS Epidemic in Black America What is AIDS? Still Standing After All This Time We Have Survived 34 AIDS Timeline 46 Viral Generation They’ve Got SWAG 72 Leadership Matters The 30 Most Influential Black AIDS Leaders People You Might Not Know, Whom You Should! Leaders to Look Out For 80 We Have the Tools 90 Presidential Report Cards 96 Recommendations 102 Appendix 1: Glossary of Terms 112 Appendix 2: Glossary of Acronyms 116 About the Institute Ver.
    [Show full text]
  • Dr. Julio Montaner Honoured As Groundbreaking Physician by Canada Post
    Journal of the BC Centre for Excellence in HIV/AIDS St. Paul’s Hospital, forecast SEPT 2020 Vancouver, B.C. Dr. Julio Montaner Honoured as Groundbreaking Physician by Canada Post his September, the BC-CfE’s Executive Director & Eric Harris, the board chair at Providence Health Care, TasP ® then became the cornerstone of UNAIDS’ 90-90- Physician-in-Chief Dr. Julio Montaner was praised Dr. Montaner, and said, “He is brilliantly fearless, 90 strategy in 2014, and recently helped inspire another honoured by Canada Post as part of their Medical to the point of being breathtaking on occasion, but it’s game-changing initiative, U=U. The U=U campaign Groundbreakers stamp series. always backed up by organization, discipline, and informs the public, healthcare professionals and policy- T ® clinical work.” makers about the tenets of TasP , that those living with The new stamps honour groundbreaking contributions HIV who are successfully on HAART treatment and have to medicine and include six Canadian physicians and Those organizational skills were on full display as an undetectable viral load are untransmittable. researchers who revolutionized their fields of health care. Dr. Montaner worked as a guiding force behind the The continued success of TasP ® in reducing new 1996 International AIDS Society Conference, where he Alongside Dr. Montaner, those chosen by Canada Post diagnoses led St. Paul’s Hospital to repurpose their introduced HAART as a new global standard of care for include Drs. Bruce Chown, Balfour Mount, M. Vera AIDS Ward in 2014 and Dr. Montaner to declare the end HIV. The 1996 conference is widely seen as a turning Peters, James Till and Ernest McCulloch.
    [Show full text]
  • 20Areas of Scientific Challenge
    L’ORÉAL-UNESCO FOR WOMEN IN SCIENCE 2018 AREAS OF SCIENTIFIC 20 CHALLENGE YEARS FOR WOMEN IN SCIENCE SUMMARY EDITORIAL 20 areas of scientific challenge 20 years For Women in Science 1 | HIV/AIDS P.10 Science advances along a continuum, with undetectable levels in people infected with discoveries large and small made through HIV. These breakthroughs have significantly 2 | GENE EDITING P.14 careful investigation or by chance in all improved survival rates: by 2014, AIDS- 3 | CANCER P.18 corners of the world. These combine to related deaths were down by 42% from their increase our understanding of physical and peak in 2004. Unprecedented global efforts 4 | HEREDITARY DISEASES P.22 biological processes, enabling us to uncover were initiated to make therapy available 5 | BRAIN DISORDERS P.26 new ways of confronting challenges or even worldwide, increasing the possibility of opening entirely new frontiers. Global eradicating the disease. 6 | MOSQUITO - BORNE DISEASES P.30 connectivity has accelerated the discovery International collaboration to solve problems 7 | EPIDEMICS AND PANDEMICS P.34 process, the dissemination of knowledge and increased as the global nature of the problems the application of breakthroughs to make a 8 | FOOD SECURITY IN AFRICA P.38 became clear: whether the threat involves difference in people’s lives. New opportunities biodiversity, air quality or influenza, actions 9 | HEART DISEASE P.42 to fight disease, generate clean energy and in one part of the Earth have broad enhance computing power have equipped 10 | BIODIVERSITY P.46 repercussions and demand new, concerted scientists with new tools and energized their approaches.
    [Show full text]
  • Biden Administration and 117Th Congress
    Updated January 15, 2021 1 Executive office of the President (EOP) The Executive Office of the President (EOP) comprises the offices and agencies that support the work of the president at the center of the executive branch of the United States federal government. To provide the President with the support that he or she needs to govern effectively, the Executive Office of the President (EOP) was created in 1939 by President Franklin D. Roosevelt. The EOP has responsibility for tasks ranging from communicating the President’s message to the American people to promoting our trade interests abroad. The EOP is also referred to as a 'permanent government', with many policy programs, and the people who implement them, continuing between presidential administrations. This is because there is a need for qualified, knowledgeable civil servants in each office or agency to inform new politicians. With the increase in technological and global advancement, the size of the White House staff has increased to include an array of policy experts to effectively address various fields. There are about 4,000 positions in the EOP, most of which do not require confirmation from the U.S. Senate. Senior staff within the Executive Office of the President have the title Assistant to the President, second-level staff have the title Deputy Assistant to the President, and third-level staff have the title Special Assistant to the President. The core White House staff appointments, and most Executive Office officials generally, are not required to be confirmed by the U.S. Senate, although there are a handful of exceptions (e.g., the Director of the Office of Management and Budget, the Chair and members of the Council of Economic Advisers, and the United States Trade Representative).
    [Show full text]
  • Harms of Criminalization of Sex Work
    HARMS OF CRIMINALIZATION OF SEX WORK: HOW END-DEMAND LEGISLATION AND IMMIGRATION POLICY SHAPE LABOUR, HEALTH AND RIGHTS AMONG IM/MIGRANT AND INDOOR SEX WORKERS IN CANADA by BRONWYN MCBRIDE M.P.H. (Global Health), Simon Fraser University, 2017 B.A. (Psychology), Simon Fraser University, 2014 A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Interdisciplinary Studies) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) July 2020 © Bronwyn McBride, 2020 i The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: Harms of criminalization of sex work: how end-demand legislation and immigration policy shape labour, health and rights among im/migrant and indoor sex workers in Canada Submitted by Bronwyn McBride in partial fulfillment of the requirements of the degree of Doctor of Philosophy in Interdisciplinary Studies Examining Committee: Dr. Kate Shannon, Medicine Co-Supervisor Dr. Shira M. Goldenberg, Health Sciences Co-Supervisor Dr. Andrea Krüsi, Medicine Supervisory Committee Member Dr. Steffanie Strathdee, Medicine Supervisory Committee Member Dr. Mieke Koehoorn, School of Population and Public Health University Examiner Dr. Becki Ross, Department of Sociology University Examiner ii Abstract Background and objectives: Globally, sex workers experience labour rights abuses, disproportionate burdens of workplace violence, and restrictions on safer ways of working (i.e., collectively and in indoor venues) due to criminalization. These inequities are often exacerbated among im/migrant sex workers, who may additionally face precarious legal status, restrictive immigration policies and racialized policing.
    [Show full text]